How much is the Lennox-Gastaut Syndrome Treatment Market market?

The lennox-gastaut syndrome treatment market market size is estimated to grow at $$ 699.8 mn in 2023. Read More

What is the growth rate of the Lennox-Gastaut Syndrome Treatment Market market?

The growth rate of the lennox-gastaut syndrome treatment market year-over-year is 4.29%. Read More

Which region held the largest market share in the Lennox-Gastaut Syndrome Treatment Market market?

North America is the region to held the largest market share with 36% growth. Read More

Who are the key players in the Lennox-Gastaut Syndrome Treatment Market market?

Akron Childrens Hospital, Amneal Pharmaceuticals Inc., Aquestive Therapeutics Inc., Bausch Health Companies Inc., Cedars Sinai Health System, Cision US Inc., Eisai Co. Ltd., Epilepsy Foundation, .... Read More

Which Segment has the largest market share in the Lennox-Gastaut Syndrome Treatment Market market?

Type is the segment that has the largest market share in the market. Read More

Lennox-Gastaut Syndrome (LGS) Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast 2024-2028

Published: Jan 2024
Pages: 161
SKU: IRTNTR74276

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global lennox-gastaut syndrome treatment market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global lennox-gastaut syndrome treatment market 2018 - 2022 ($ million)

4.2 Type Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ million)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Type - Market share 2023-2028 (%)

6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type

6.3 Non-surgical treatment - Market size and forecast 2023-2028
- Exhibit 34: Chart on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Non-surgical treatment - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Non-surgical treatment - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Non-surgical treatment - Year-over-year growth 2023-2028 (%)

6.4 Surgical treatment - Market size and forecast 2023-2028
- Exhibit 38: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Type
- Exhibit 42: Market opportunity by Type ($ million)
- Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 46: Chart on Comparison by End-user
- Exhibit 47: Data Table on Comparison by End-user

7.3 Hospitals - Market size and forecast 2023-2028
- Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)

7.4 Specialty clinics - Market size and forecast 2023-2028
- Exhibit 52: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)

7.5 Others - Market size and forecast 2023-2028
- Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by End-user
- Exhibit 60: Market opportunity by End-user ($ million)
- Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 Canada - Market size and forecast 2023-2028
- Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.10 UK - Market size and forecast 2023-2028
- Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.11 China - Market size and forecast 2023-2028
- Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 Akron Childrens Hospital
- Exhibit 111: Akron Childrens Hospital - Overview
- Exhibit 112: Akron Childrens Hospital - Product / Service
- Exhibit 113: Akron Childrens Hospital - Key offerings

12.4 Cedars Sinai Health System
- Exhibit 114: Cedars Sinai Health System - Overview
- Exhibit 115: Cedars Sinai Health System - Product / Service
- Exhibit 116: Cedars Sinai Health System - Key offerings

12.5 Cision US Inc.
- Exhibit 117: Cision US Inc. - Overview
- Exhibit 118: Cision US Inc. - Product / Service
- Exhibit 119: Cision US Inc. - Key offerings

12.6 Eisai Co. Ltd.
- Exhibit 120: Eisai Co. Ltd. - Overview
- Exhibit 121: Eisai Co. Ltd. - Business segments
- Exhibit 122: Eisai Co. Ltd. - Key offerings
- Exhibit 123: Eisai Co. Ltd. - Segment focus

12.7 Epilepsy Foundation
- Exhibit 124: Epilepsy Foundation - Overview
- Exhibit 125: Epilepsy Foundation - Product / Service
- Exhibit 126: Epilepsy Foundation - Key offerings

12.8 GlaxoSmithKline Plc
- Exhibit 127: GlaxoSmithKline Plc - Overview
- Exhibit 128: GlaxoSmithKline Plc - Business segments
- Exhibit 129: GlaxoSmithKline Plc - Key news
- Exhibit 130: GlaxoSmithKline Plc - Key offerings
- Exhibit 131: GlaxoSmithKline Plc - Segment focus

12.9 H Lundbeck AS
- Exhibit 132: H Lundbeck AS - Overview
- Exhibit 133: H Lundbeck AS - Product / Service
- Exhibit 134: H Lundbeck AS - Key offerings

12.10 Johnson and Johnson
- Exhibit 135: Johnson and Johnson - Overview
- Exhibit 136: Johnson and Johnson - Business segments
- Exhibit 137: Johnson and Johnson - Key news
- Exhibit 138: Johnson and Johnson - Key offerings
- Exhibit 139: Johnson and Johnson - Segment focus

12.11 Lupin Ltd.
- Exhibit 140: Lupin Ltd. - Overview
- Exhibit 141: Lupin Ltd. - Product / Service
- Exhibit 142: Lupin Ltd. - Key news
- Exhibit 143: Lupin Ltd. - Key offerings

12.12 Marinus Pharmaceuticals Inc.
- Exhibit 144: Marinus Pharmaceuticals Inc. - Overview
- Exhibit 145: Marinus Pharmaceuticals Inc. - Product / Service
- Exhibit 146: Marinus Pharmaceuticals Inc. - Key offerings

12.13 Sawai Group Holdings Co. Ltd.
- Exhibit 147: Sawai Group Holdings Co. Ltd. - Overview
- Exhibit 148: Sawai Group Holdings Co. Ltd. - Product / Service
- Exhibit 149: Sawai Group Holdings Co. Ltd. - Key offerings

12.14 Supernus Pharmaceuticals Inc.
- Exhibit 150: Supernus Pharmaceuticals Inc. - Overview
- Exhibit 151: Supernus Pharmaceuticals Inc. - Product / Service
- Exhibit 152: Supernus Pharmaceuticals Inc. - Key offerings

12.15 Teva Pharmaceutical Industries Ltd.
- Exhibit 153: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 154: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 155: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 156: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 157: Teva Pharmaceutical Industries Ltd. - Segment focus

12.16 UCB SA
- Exhibit 158: UCB SA - Overview
- Exhibit 159: UCB SA - Product / Service
- Exhibit 160: UCB SA - Key offerings

12.17 Viatris Inc.
- Exhibit 161: Viatris Inc. - Overview
- Exhibit 162: Viatris Inc. - Business segments
- Exhibit 163: Viatris Inc. - Key news
- Exhibit 164: Viatris Inc. - Key offerings
- Exhibit 165: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 166: Inclusions checklist
- Exhibit 167: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 168: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 169: Research methodology
- Exhibit 170: Validation techniques employed for market sizing
- Exhibit 171: Information sources

13.5 List of abbreviations
- Exhibit 172: List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES